The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
Open accessAbstract
BACKGROUND: Cerebral malaria is a severe complication of Plasmodium falciparum infection in children, with a mortality rate of 15 to 50 percent despite antimalarial therapy. METHODS: To determine whether combining iron chelation with quinine therapy speeds the recovery of consciousness, we conducted a randomized, double-blind, placebo-controlled trial of the iron chelator deferoxamine in 83 Zambian children with cerebral malaria. To be enrolled, patients had to be less than six years old, have P. falciparum parasitemia, have normal cerebrospinal fluid without evidence of bacterial infection, and be in a coma from which they could not be aroused. Deferoxamine (100 mg per kilogram of body weight per day, infused intravenously for 72 hours) or placebo was added to standard therapy with quinine and sulfadoxine-pyrimethamine. The time to the recovery of full consciousness, time to parasite clearance, and mortality were examined with Cox proportional-hazards regression analysis. RESULTS: The rate of recovery of full consciousness among the 42 patients given deferoxamine was 1.3 times that among the 41 given placebo (95 percent confidence interval, 0.7 to 2.3); the median time to recovery was 20.2 hours in the deferoxamine group and 43.1 hours in the placebo group (P = 0.38). Among 50 patients with deep coma, the rate of recovery of full consciousness was increased 2.2-fold with deferoxamine (95 percent confidence interval, 1.1 to 4.7), decreasing the median recovery time from 68.2 to 24.1 hours (P = 0.03). Among 69 patients for whom data on parasite clearance were available, the rate of clearance with deferoxamine was 2.0 times that with placebo (95 percent confidence interval, 1.2 to 3.6). Among all 83 patients, mortality was 17 percent in the deferoxamine group and 22 percent in the placebo group (P = 0.52). CONCLUSIONS: Iron chelation therapy may hasten the clearance of parasitemia and enhance recovery from deep coma in cerebral malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Along this line children suffering from cerebral malaria benefited from the addition of the iron chelator desferrioxamine to a standard anti-malaria treatment, as reflected by faster recurrence from coma and clearance of plasmodia, although this did not translate into a survival benefit (Gordeuk et al., 1992; Mabeza et al., 1999), although anti-plasmodial innate immune responses were positively”
From Iron at the interface of immunity and infection (2014) · cites this paper as Gordeuk et al., 1992
Experimental — accuracy not yet measuredIn the citing paper
“the malarial parasite Plasmodium falciparum requires considerable iron for growth, and there is evidence that lowering the amount of available iron provides a promising route to antimalarials (e.g. [1478-1494]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1481]
In the citing paper
“Systemic Fe chelation by desferrioxamine can improve the clinical course of malaria, without, however, providing an overt survival benefit [236].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [236]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
MacPherson, G. G., Warrell, M. J., White, N. J., Looareesuwan, S., & Warrell, D. A. (1985) · PubMed Central · Cited by 825
Molyneux, M. E., Taylor, T. E., Wirima, J. J., & Borgstein, A. (1989) · QJM · doi:10.1093/oxfordjournals.qjmed.a068338 · Cited by 691
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.
Henson, P. M., & Johnston, R. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112869 · Cited by 688
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa
Greenwood, B. M., Bradley, A. K., Greenwood, A. M., Byass, P., Jammeh, K., Marsh, K., Tulloch, S., Oldfield, F. S. J., & Hayes, R. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90170-2 · Cited by 622
Hemoglobin. A biologic fenton reagent.
Sadrzadeh, S. M. H., Graf, E., Panter, S. S., Hallaway, P. E., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42604-4 · Cited by 589
Neurological sequelae of cerebral malaria in children
Brewster, D., Kwiatkowski, D. P., & White, N. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92498-7 · Cited by 407
Aikawa, M. (1988) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.39.3 · Cited by 343
Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.
Ward, P. A., Till, G. O., Kunkel, R., & Beauchamp, C. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111050 · Cited by 336
Research works printed but not linked: 3
- Molyneux, 1989, Q J Med, 71, 441
- 1978, WHO Chron, 32, 9
- MacPherson, 1985, Am J Pathol, 119, 385
Cited by
Sorted by citations
World Health Organization (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90300-6 · Cited by 1,110
Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Stoltzfus, R. J., Dutta, A., Dhingra, U., Kabole, I., Deb, S., Othman, M. K., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67962-2 · Cited by 981
Iron and Its Relation to Immunity and Infectious Disease
Oppenheimer, S. J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.616s · Cited by 695
Oxidative stress in malaria parasite-infected erythrocytes: host–parasite interactions
Becker, K., Tilley, L. M., Vennerstrom, J. L., Roberts, D. J., Rogerson, S. J., & Ginsburg, H. (2003) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.09.011 · Cited by 665
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Iron, anaemia, and inflammatory bowel diseases
Gasché, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 501
Iron metabolism, free radicals, and oxidative injury
Emerit, J., Beaumont, C., & Trivin, F. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00068-3 · Cited by 454
Murphy, S., & Breman, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.57 · Cited by 451
Iron regulates nitric oxide synthase activity by controlling nuclear transcription.
Weiss, G., Werner-Felmayer, G., Werner, E. R., Grünewald, K., Wachter, H., & Hentze, M. W. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.969 · Cited by 412
Newton, C. R. J. C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00008-4 · Cited by 349
Iron at the interface of immunity and infection
Nairz, M., Haschka, D., Demetz, E., & Weiss, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00152 · Cited by 325
“…treatment, as reflected by faster recurrence from coma and clearance of plasmodia, although this did not translate into a survival benefit (Gordeuk et al., 1992; Mabeza et al., 1999), although anti-plasmodial innate immune responses were positively affected by iron chelation in vivo…”
BackgroundIron metabolism in the anemia of chronic disease
Weiss, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.006 · Cited by 322
Iron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317
Nutritional Modulation of Malaria Morbidity and Mortality
Shankar, A. H. (2000) · The Journal of Infectious Diseases · doi:10.1086/315906 · Cited by 296
Pathogenesis and treatment of anaemia of chronic disease
Weiß, G. (2002) · Blood Reviews · doi:10.1054/blre.2002.0193 · Cited by 276
Iron metabolism and the innate immune response to infection
Johnson, E. E., & Wessling-Resnick, M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.001 · Cited by 253
“Iron chelation has been found to improve coma in children with cerebral malaria [95].”
BackgroundThe Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Cerebral malaria
Newton, C. R. J. C. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.4.433 · Cited by 220
Clinical Features and Outcome of Severe Malaria in Gambian Children
Waller, D., Krishna, S., Crawley, J., Miller, K. M., Nosten, F. H., Chapman, D., ter Kuile, F. O., Craddock, C., Berry, C., Holloway, P. A. H., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.577 · Cited by 214
Iron Deficiency Protects Against Severe Plasmodium falciparum Malaria and Death in Young Children
Gwamaka, M., Kurtis, J. D., Sorensen, B. E., Holte, S., Morrison, R., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis010 · Cited by 197
Diagnosis and management of the neurological complications of falciparum malaria
Mishra, S. K., & Newton, C. R. J. C. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.23 · Cited by 180
Ferritin: An Inflammatory Player Keeping Iron at the Core of Pathogen-Host Interactions
Moreira, A. C., Mesquita, G., & Gomes, M. S. (2020) · Microorganisms · doi:10.3390/microorganisms8040589 · Cited by 172
Modification of iron regulation by the inflammatory response
WEISS, G. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.001 · Cited by 161
Shibahara, S. (2003) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.200.167 · Cited by 153
Hemoglobin catabolism and iron utilization by malaria parasites
Rosenthal, P. J. (1996) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(96)02763-6 · Cited by 158
Pathophysiology of fatal falciparum malaria in African children.
Newton, C. R. J. C., Taylor, T. E., & Whitten, R. O. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.58.673 · Cited by 151
Nutritional iron deficiency: an evolutionary perspective
Denic, S., & Agarwal, M. (2007) · Nutrition · doi:10.1016/j.nut.2007.05.002 · Cited by 140
Adjunctive therapy for cerebral malaria and other severe forms ofPlasmodium falciparummalaria
John, C. C., Kutamba, E., Mugarura, K., & Opoka, R. O. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.90 · Cited by 132
Iron and infection: competition between host and microbes for a precious element
MARX, J. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2002.0001 · Cited by 129
Oxidative stress in malaria; implications for prevention and therapy
Postma, N. S., Zuidema, J., Momm�rs, E. C., & Eling, W. M. C. (1996) · Pharmacy World & Science · doi:10.1007/bf00717727 · Cited by 134
Proteases of Malaria Parasites: New Targets for Chemotherapy
Rosenthal, P. J. (1998) · Emerging infectious diseases · doi:10.3201/eid0401.980107 · Cited by 127
Malaria: New Developments in Treatment and Prevention
Newton, B. P., & White, N. J. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.179 · Cited by 126
Adjunctive therapy for severe malaria: a review and critical appraisal
Varo, R., Crowley, V. M., Sitoe, A., Madrid, L., Serghides, L., Kain, K. C., & Bassat, Q. (2018) · Malaria Journal · doi:10.1186/s12936-018-2195-7 · Cited by 127
Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans.
Miller, L. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2415 · Cited by 123
The Role of Iron In Protozoan and Fungal Infectious Diseases
Weinberg, E. D. (1999) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.1999.tb05119.x · Cited by 115
Pentoxifylline as a Supportive Agent in the Treatment of Cerebral Malaria in Children
Perri, G. D., Perri, I. G. D., Monteiro, G. B., Bonora, S., Hennig, C., Cassatella, M. A., Micciolo, R., Vento, S., Dusi, S., Bassetti, D., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1317 · Cited by 112
Iron Chelation Therapy for Malaria
Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00037-0 · Cited by 111
Self-citationIron chelating agents in clinical practice
Faa, G., & Crisponi, G. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)00056-9 · Cited by 108
Casals‐Pascual, C., Idro, R., Gicheru, N., Gwer, S., Kitsao, B. S., Gitau, E., Mwakesi, R., Roberts, D. J., & Newton, C. R. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709715105 · Cited by 106
Walther, M., De Caul, A., Aka, P., Njie, M., Amambua-Ngwa, A., Walther, B., Predazzi, I. M., Cunnington, A., Deininger, S., Takem, E. N., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002579 · Cited by 98
Hershko, C. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80133-7 · Cited by 97
Coma scales for children with severe falciparum malaria
Newton, C. R. J. C., Chokwe, T., Schellenberg, J., Winstanley, P., Forster, D., Peshu, N. M., Kirkham, F. J., & Marsh, K. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90207-8 · Cited by 94
Mung’ala‐Odera, V., Snow, R. W., & Newton, C. R. J. C. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.64 · Cited by 86
Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths
Schenck, J. F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00203-e · Cited by 85
Rosenberg, P. A., Li, Y., Ali, S., Altıok, N., Back, S. A., & Volpe, J. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730476.x · Cited by 86
Fritsche, G., Larcher, C., Schennach, H., & Weiss, G. (2001) · The Journal of Infectious Diseases · doi:10.1086/319860 · Cited by 84
Neurological manifestations of falciparum malaria
Newton, C. R. J. C., & Warrell, D. A. (1998) · Annals of Neurology · doi:10.1002/ana.410430603 · Cited by 84
Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria
Thuma, P. E., Mabeza, G. F., Biemba, G., Bhat, G. J., McLaren, C. E., Moyo, V. M., Zulu, S., Khumalo, H., Mabeza, P., M'Hango, A., et al. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90753-2 · Cited by 76
Self-citationTakeda, M., Kikuchi, M., Ubalee, R., Na‐Bangchang, K., Ruangweerayut, R., Shibahara, S., Imai, S.-I., & Hirayama, K. (2005) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2005.268 · Cited by 74
Theurl, I., Fritsche, G., Ludwiczek, S., Garimorth, K., Bellmann-Weiler, R., & Weiss, G. (2005) · BioMetals · doi:10.1007/s10534-005-3710-1 · Cited by 72
Urquhart, A. D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.1.117 · Cited by 70
dos Santos, A. L. S., Sodré, C. L., Valle, R. S., da Silva, B. A. S., Abi-chacra, É. A., Silva, L. V., Souza-Gonçalves, A. L., Sangenito, L. S., Gonçalves, D. D. S., Souza, L. O., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609788 · Cited by 71
Bioavailable Iron and Heme Metabolism in Plasmodium falciparum
Scholl, P. F., Tripathi, A. K., & Sullivan, D. J. (2005) · Springer eBooks · doi:10.1007/3-540-29088-5_12 · Cited by 69
Salmon, D., Fontbonne, A., Saba, J., May, T., Raffi, F., Chidiac, C., Aboulker, J.-P., Schwartz, D., Vile, J. L., & the Study Group (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.3.656 · Cited by 65
Iron Acquisition by Parasitic Protozoa
Wilson, M. E., & Britigan, B. E. (1998) · Parasitology Today · doi:10.1016/s0169-4758(98)01294-0 · Cited by 64
Ferrous Iron Uptake in Cryptococcus neoformans
Jacobson, E. S., Goodner, A. P., & Nyhus, K. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.9.4169-4175.1998 · Cited by 62
Iron chelators as therapeutic agents against Pneumocystis carinii
Weinberg, G. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.997 · Cited by 59
Rasoloson, D., Shi, L., Chong, C. R., Kafsack, B. F. C., & Sullivan, D. J. (2004) · Biochemical Journal · doi:10.1042/bj20040335 · Cited by 58
Ferrer, P., Tripathi, A. K., Clark, M. A., Hand, C. C., Rienhoff, H. Y., & Sullivan, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037171 · Cited by 58
Benefits and risks of iron therapy for chronic anaemias
Weiss, G., & Gordeuk, V. R. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01529.x · Cited by 54
Self-citationHershko, C. (2007) · Food and Nutrition Bulletin · doi:10.1177/15648265070284s403 · Cited by 54
Iron as a target of chemoprevention for longevity in humans
Toyokuni, S. (2011) · Free Radical Research · doi:10.3109/10715762.2011.564170 · Cited by 53
Iron-chelating agents for treating malaria
Smith, H. J. J., & Meremikwu, M. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001474 · Cited by 52
Modulatory Potential of Iron Chelation Therapy on Nitric Oxide Formation in Cerebral Malaria
Weiss, G., Thuma, P. E., Mabeza, G. F., Werner, E. R., Herold, M., & Gordeuk, V. R. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.1.226 · Cited by 52
Self-citationSuperinfection in malaria: Plasmodium shows its iron will
Portugal, S., Drakesmith, H., & Mota, M. M. (2011) · EMBO Reports · doi:10.1038/embor.2011.213 · Cited by 55
Management of severe paediatric malaria in resource-limited settings
Maitland, K. (2015) · BMC Medicine · doi:10.1186/s12916-014-0263-6 · Cited by 51
Murata, K., Takano, F., Fushiya, S., & Oshima, Y. (1998) · Journal of Natural Products · doi:10.1021/np970433o · Cited by 48
Convulsions in childhood malaria
Wattanagoon, Y., Srivilairit, S., Looareesuwan, S., & White, N. J. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90415-4 · Cited by 48
Weiß, G., Umlauft, F., Urbanek, M., Herold, M., Lovevsky, M., Offner, F. A., & Gordeuk, V. R. (1999) · The Journal of Infectious Diseases · doi:10.1086/315052 · Cited by 48
Self-citationClark, M. A., Fisher, N. C., Kasthuri, R. S., & Hand, C. C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12234 · Cited by 47
Adjuvant therapy in cerebral malaria.
Mohanty, S., Patel, D. K., Pati, S. S., & Mishra, S. K. (2006) · PubMed · Cited by 47
Sangaré, L. R., van Eijk, A. M., ter Kuile, F. O., Walson, J. L., & Stergachis, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087743 · Cited by 46
Managing malaria in the intensive care unit
Marks, M., Gupta‐Wright, A., Doherty, J. F., Singer, M., & Walker, D. A. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu157 · Cited by 44
Not much progress in treatment of cerebral malaria
White, N. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79572-6 · Cited by 44
Weiss, G., Thuma, P. E., Biemba, G., Mabeza, G. F., Werner, E. R., & Gordeuk, V. R. (1998) · The Journal of Infectious Diseases · doi:10.1086/515229 · Cited by 44
Self-citationThe therapeutic potential of iron chelators
Richardson, D. R. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2141 · Cited by 42
Liposomes for malaria management: the evolution from 1980 to 2020
Memvanga, P. B., & Nkanga, C. I. (2021) · Malaria Journal · doi:10.1186/s12936-021-03858-0 · Cited by 45
Effects of iron deprivation on Mycobacterium avium growth
Gomes, M. S., Dom, G., Pedrosa, J., Boelaert, J. R., & Appelberg, R. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0216 · Cited by 41
ZIPCO, a putative metal ion transporter, is crucial for Plasmodium liver‐stage development
Sahu, T., Boisson, B., Lacroix, C., Bischoff, E., Richier, Q., Formaglio, P., Thiberge, S., Dobrescu, I., Ménard, R., & Baldacci, P. A. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403868 · Cited by 43
Weiß, G., Loyevsky, M., & Gordeuk, V. R. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00100-1 · Cited by 40
Self-citationIron Chelators as antimalarials: the biochemical basis of selective cytotoxicity
Cabantchik, Z. I. (1995) · Parasitology Today · doi:10.1016/0169-4758(95)80123-5 · Cited by 40
Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand
BUNNAG, D., Poltera, A. A., Viravan, C., Looareesuwan, S., Harinasuta, T., & Schindléry, C. (1992) · Acta Tropica · doi:10.1016/0001-706x(92)90007-k · Cited by 40
Self-citationEffect of iron chelation on the in-vitro growth of leishmania promastigotes
Soteriadou, K., Papavassiliou, P., Voyiatzaki, C., & Boelaert, J. R. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.23 · Cited by 39
Evolutionary biology and the concept of disease
Gammelgaard, A. (2000) · Medicine Health Care and Philosophy · doi:10.1023/a:1009999502884 · Cited by 38
Implications of resource‐ratio theory for oral microbial ecology
Smith, V. H., & Pippin, D. J. (1998) · European Journal Of Oral Sciences · doi:10.1046/j.0909-8836..t01-4-.x · Cited by 38
Schümann, K., Solomons, N. W., Romero‐Abal, M., Orozco, M., Weiss, G., & Marx, J. J. M. (2012) · Food and Nutrition Bulletin · doi:10.1177/156482651203300206 · Cited by 36
Schlapbach, R., Spanaus, K., Malipiero, U., Lens, S. M. A., Tasinato, A., Tschopp, J., & Fontana, A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12 · Cited by 74
Synthesis of glycosylated β-Amino hydroxamates as new class of antimalarials
Mishra, R. C., Tripathi, R., Katiyar, D., Tewari, N., Singh, D., & Tripathi, R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.038 · Cited by 35
In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum
Pradines, B. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl117 · Cited by 35
Recent developments and rationale towards new strategies for malarial chemotherapy
Vial, H. J. (1996) · Parasite · doi:10.1051/parasite/1996031003 · Cited by 34
Newman, S. L., Gootee, L., Stroobant, V., der Goot, H. V., & Boelaert, J. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1824 · Cited by 35
Mair, S. M., Nairz, M., Bellmann-Weiler, R., Muehlbacher, T., Schroll, A., Theurl, I., Moser, P. L., Talasz, H., Fang, F. C., & Weiss, G. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir395 · Cited by 33
Hackett, M. J., Aitken, J. B., El‐Assaad, F., McQuillan, J. A., Carter, E. A., Ball, H. J., Tobin, M. J., Paterson, D., de Jonge, M. D., Siegele, R., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500911 · Cited by 35
Enwere, G. (2005) · Tropical medicine & international health · doi:10.1111/j.1365-3156.2005.01505.x · Cited by 31
Malaria and iron: history and review
Weinberg, E. D., & Moon, J. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530903178905 · Cited by 34
Thuma, P. E., Olivieri, N. F., Mabeza, G. F., Biemba, G., Parry, D., Zulu, S., Fassos, F. F., MCCLELLAND, R. A., Koren, G., Brittenham, G. M., et al. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.58.358 · Cited by 32
Self-citationIn vitro activities of novel catecholate siderophores against Plasmodium falciparum
Pradines, B., Ramiandrasoa, F., Basco, L. K., Bricard, L., Kunesch, G., & Bras, J. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2094 · Cited by 31
Arantes, J. M., Pedrosa, M. L., Martins, H. R., Veloso, V. M., de Lana, M., Bahia, M. T., Tafuri, W. L., & Carneiro, C. M. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.03.006 · Cited by 31
Effects of zinc-desferrioxamine on Plasmodium falciparum in culture
Chevion, M., Chuang, L., & Golenser, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1902 · Cited by 30
Iron chelators as anti-infectives; malaria as a paradigm
Cabantchik, Z. I., Moody-Haupt, S., & Gordeuk, V. R. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01401.x · Cited by 29
Self-citation
Metadata
- Authors
- Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., Vargas, L., Gilkeson, R., & Poltera, A. A.
- Affiliations
- MetroHealth Medical Center (US)
- Pennsylvania State University (US)
- Minnesota State University Moorhead (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-11-19
- Volume
- 327
- Issue
- 21
- Pages
- 1473-1477
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983646126
- Cited by
- 210
- References
- 23
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 4 · 2018: 3 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 4 · 2012: 6
- FWCI
- 19.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl042814-05)
- U.S. Food and Drug Administration (FD-R-000657-01)
- National Heart, Lung, and Blood Institute (R01 HL42814-02)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- cerebral malaria, iron chelation, deferoxamine, deep coma, consciousness recovery, Plasmodium falciparum, quinine, sulfadoxine-pyrimethamine, parasite clearance, mortality, children
- MeSH terms
- Child, Preschool, Coma, Consciousness, Deferoxamine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Pyrimethamine, Quinine, Sulfadoxine, Time Factors, Proportional Hazards Models, Malaria, Cerebral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
